Expects increasing contributions from new products across the portfolio. Says making progress with biosimilar strategy. Says pipeline continues to be highly productive. Comments taken from Q3 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Morning Movers: BofA, Morgan Stanley jump following Q3 results
- Abbott reports Q3 adjusted EPS $1.30, consensus $1.30
- Abbott narrows FY25 adjusted EPS view to $5.12-$5.18 from $5.10-$5.20
- Options Volatility and Implied Earnings Moves Today, October 15, 2025
- Notable companies reporting before tomorrow’s open